Intellectual Property Law Committee (1/26/21)

TOPIC: How Patent Infringement Concerns May Shape COVID-19 Vaccine Development and Deployment

DESCRIPTION: The COVID-19 pandemic has driven pharmaceutical companies around the world to shift their focus to develop a safe and effective vaccine and/or therapeutic treatment as quickly as possible. However, the urgency and speed at which research and trials are being conducted leaves little time for companies to assess legal risks – including potential patent infringement. This program will provide an in-depth discussion of the options available to the Federal Government to shield potential infringers from liability in order to accelerate vaccine delivery and meet public demand. Also discussed will be how patent damages may be assessed in light of this unprecedented situation if companies are not immunized of infringement by the government.

SPEAKER(S)/ORGANIZATION:  David Duski is a Director in BDO’s Forensic Investigation and Litigation Services group and leads its intellectual property consulting practice. Throughout his career, David has provided dispute resolution services for cases involving patent infringement, trademark infringement, trade secret misappropriation, false advertising, breach of contract, business interruption, legal malpractice, and product liability, among others. He has also provided financial and economic consulting for attorneys and corporate clients.

(Live Webcast Only: IL MCLE Credit)

  

To confirm you are ready to participate in an on demand webcast, please take the browser test here: http://eventcenter.commpartner...

Live CBA Committee meetings and seminars will take place via Zoom webinar.  You will click on "view video" and be directly connected to the meeting/seminar on Zoom.  (You will not receive a Zoom link.)

You MUST have Zoom Desktop Client on your Mac or PC to view a live program. If using a mobile device, you must have the Zoom App (available in the App Store or Google Play).

System requirements for Mac & PC can be found here. System requirements for mobile devices can be here.  

Please note that audience members do not need video or audio access.  Audience members are able to submit questions via the chat or Q & A features of Zoom. 

Chat: Open in-meeting chat, allowing you to send chat messages to and send a message to the host, panelists, and attendees (if permitted). Question & Answer: Open the Q&A window, allowing you to ask questions to the host and panelists. They can either reply back to you via text in the Q&A window or answer your question live. 

Key:

Complete
Failed
Available
Locked
Intellectual Property Law Committee (1/26/21)
Open to view video.
Open to view video.
Evaluation (committee meeting)
5 Questions